Follow-up study of enzymuria and ? 2 microglobulinuria during cis-platinum treatment

European Journal of Clinical Pharmacology - Tập 29 Số 3 - Trang 313-318 - 1985
Antonio Tirelli1, Nicoletta Colombo1, G Cavanna1, Costantino Mangioni1, B.M. Assael1
1Departments of Pediatrics and Obstetrics and Gynecology, University of Milan Medical School, Milan, Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo

Harrap K, Jones M, Ray Wilkinson C et al. (1980) In: Prestayko AW et al. (eds) Cisplatin. Academic Press, New York, pp 193?212

Gonzales-Vitale JC, Hayes DM, Cvitkovic E, Sternberg S (1977) Renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer 39: 1362?1371

Hall DJ, Diasio R, Goplerud DR (1981) Cis-platinum in gynecologic cancer. III Toxicity. Am J Obstet Gynecol 141: 309?312

Blachley JD, Hill JB (1981) Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 95: 628?632

Comis RL (1980) In: Prestayko AW et al. (eds) Cisplatin. Academic Press New York pp 485?494

Hayes DM, Cvitkovic E, Golbey RB et al. (1977) High dose cis-platinum diamminedichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer 39: 1372?1381

Vogl SE, Zaravinos T, Kaplan BH (1980) Toxicity of cisdiamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydration. Cancer 45: 11?15

Guarino AM, Miller DS, Arnold ST, Pritchard JB et al. (1979) Platinate toxicity: Past, present and prospects. Cancer Treat Rep 63: 1475?1483

Choie DD, Longnecker DS, Del Campo AA (1981) Acute and chronic cisplatin nephropathy in rats. Lab Invest 44: 397?402

Kovacs CJ, Braunschweiger PG, Schenken LL, Burholt DR (1982) Proliferative defects in renal and intestinal epithelium after cis-diamminedichloroplatinum (II). Br J Cancer 45: 286?294

Diener U, Knoll E, Langer B, Rautenstrauch H, Ratge D, Wisser H (1981) Urinary excretion of N-acetyl-?-D-glucosaminidase in patients receiving amikacin or cisplatinum. Clin Chim Acta 112: 149?157

Jones BR, Ravi B, Bhalla BS, Mladek J, Kaleya RN et al. (1980) Comparison of methods of evaluating nephrotoxicity of cis-platinum. Clin Pharmacol Ther 27: 557?562

Cohen AI, Harberg J, Citrin DL (1981) Measurement of urinary ? 2 microglobulin in the detection of cisplatin nephrotoxicity. Cancer Treat Rep 65: 1083?1085

Kuhn JA, Argy WP, Rakowski TA et al. (1980) Nephrotoxicity of cis-diamminedichloroplatinum (II) as measured by urinary ?-glucorinidase. Cancer Treat Rep 64: 1083?1086

Leaback H, Walker PG (1961) Studies on glucosaminidase: IV. The fluorimetric assay of N-acetyl-?-glucosaminidase. Biochem J 78: 151?156

Gilbert DN, Houghton DC, Bennet WM, Plamp CE, Reger K, Porter GA (1979) Reversibility of gentamicin nephrotoxicity in rat: Recovery during continous drug administration. Proc Soc Exp Biol Med 160: 99?103

Luft FC, Rankin LI, Sloan RS (1978) Recovery from Aminoglycoside nephrotoxicity with continued drug administration. Antimicrob Agents Chemother 3: 284?287

Evrin PE, Peterson PA, Wide L, Berggard J (1971) Radio-immunoassay of ? 2 microglobulin in human biological fluids Scand J Clin Lab Invest 28: 439?444

Roger E, Kirk A (1968) Experimental design procedures for the behavioral sciences. Brooks/Cole Publishing Company, Belmont California